0A8E Intrinsic Valuation and Fundamental Analysis - Xeris Biopharma Holdings Inc

	Xeris Biopharma Holdings Inc LSE:0A8E	US
	One Stop Systems Inc NASDAQ:OSS	US
E	eHealth Inc F:M5V	US

Intrinsic Value

The intrinsic value for Xeris Biopharma Holdings Inc (0A8E) under the Base Case is 6.6403 USD. Compared with the current market price of 8.8395 USD, the stock appears Overvalued by 25% .

DCF Value

$6.8541

Multiples-Based Value

$6.4265

DCF Value

$6.8541

Multiples-Based Value

$6.4265

Both DCF and multiples point to overvaluation.

Why combine DCF with multiples? What is Intrinsic Value?

0A8E Intrinsic Value

Overvaluation 25%

Intrinsic Value

Price $8.8395

Bear Case

Base Case

Bull Case

Track Buy Zone

20% below Intrinsic Value $5.31

Get notified when the price drops into your buy zone

Current Price $8.84

Intrinsic Value $6.64

Margin of Safety 20% $5.31

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Xeris Biopharma Holdings Inc.

Explain Valuation